Inventor · disambiguated record
Yasufumi Kaneda
Also filed as: KANEDA YASUFUMI
26 granted patents·22 pending applications·483 citations·filing 1994–2024
96Inventor score
Top patents by PatentIndex Score
48 records- 0195US6472375B1DNA vaccine and methods for its useWAYNE JOHN CANCER INST·Filed 1998·Granted Oct 29, 2002·178 cites·33 claims
- 0294US5631237AMethod for producing in vivo delivery of therapeutic agents via liposomesFiled 1994·Granted May 20, 1997·166 cites·10 claims
- 0388US2025090634A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2024·Application pending·0 cites
- 0486US8673580B2Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulationTAMAI KATSUTO·Filed 2009·Granted Mar 18, 2014·13 cites·7 claims
- 0585US9919010B2Method for collecting functional cells in vivo with high efficiencyTAMAI KATSUTO·Filed 2009·Granted Mar 20, 2018·4 cites·27 claims
- 0684US6913923B2Virus envelope vector for gene transferANGES MG INC·Filed 2001·Granted Jul 5, 2005·16 cites·7 claims
- 0783US7871765B2Composition having antitumor effectGENOMIDEA INC·Filed 2005·Granted Jan 18, 2011·6 cites·2 claims
- 0883US7807176B2Polypeptide promoting vascular endothelial cell growthGENOMIDEA INC·Filed 2005·Granted Oct 5, 2010·6 cites·9 claims
- 0980US9623078B2Method for treating cardiac infarction using HMGB1 fragmentGENOMIX CO LTD·Filed 2013·Granted Apr 18, 2017·8 cites·1 claims
- 1080US7803621B2Virus envelope vector for gene transferANGES MG INC·Filed 2005·Granted Sep 28, 2010·3 cites·17 claims
- 1180US6432925B1RNA cancer vaccine and methods for its useWAYNE JOHN CANCER INST·Filed 1998·Granted Aug 13, 2002·54 cites·87 claims
- 1276US7279333B2Virus envelope vector for gene transferANGES MG INC·Filed 2004·Granted Oct 9, 2007·6 cites·11 claims
- 1375US7427395B2Chemotherapeutic agent-incorporated pharmaceutical preparationGENOMIDEA INC·Filed 2003·Granted Sep 23, 2008·8 cites·23 claims
- 1475US7247620B2Method of treating skin wounds with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2002·Granted Jul 24, 2007·6 cites·7 claims
- 1573US7504098B2Method for introducing a biological molecule using a viral envelope and heparin and system thereforeANGES MG INC·Filed 2005·Granted Mar 17, 2009·2 cites·2 claims
- 1673US2022088141A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2021·Application pending·0 cites
- 1772US11191786B2Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into bloodTAMAI KATSUTO·Filed 2010·Granted Dec 7, 2021·1 cites·6 claims
- 1870US2024050460A1Pharmaceuticals That Promote Functional Regeneration of Damaged TissuesSTEMRIM INC·Filed 2023·Application pending·0 cites
- 1969US7858356B2Mutant paramyxovirus and method for production thereofGENOMIDEA INC·Filed 2006·Granted Dec 28, 2010·2 cites·22 claims
- 2068US2011160132A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2006·Application pending·0 cites
- 2167US7939504B2Method of treating skin ulcers with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2007·Granted May 10, 2011·0 cites·7 claims
- 2266US2019321444A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2019·Application pending·0 cites
- 2364US8691212B2Therapeutic/prophylactic agent for prostate cancerKANEDA YASUFUMI·Filed 2009·Granted Apr 8, 2014·1 cites·9 claims
- 2463US7390482B2Drug for auditory dysfunctionANGES MG INC·Filed 2003·Granted Jun 24, 2008·1 cites·2 claims
- 2562US7259149B2Methods for treating or preventing angiogenesis-dependent symptomsANGES MG INC·Filed 2003·Granted Aug 21, 2007·2 cites·4 claims
- 2661US2022047642A1Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into bloodSTEMRIM INC·Filed 2021·Application pending·0 cites
- 2758US11197895B2Method for collecting functional cells in vivo with high efficiencySTEMRIM INC·Filed 2017·Granted Dec 14, 2021·0 cites·20 claims
- 2857US2008312130A1Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the sameGENOMLDEA INC·Filed 2008·Application pending·0 cites
- 2957US2009105183A1Pharmaceutical composition containing decoy and method of using the sameANGES MG INC·Filed 2008·Application pending·0 cites
- 3056US10441613B2Anti-cancer agent comprising HVJ-E and CXCL2UNIV OSAKA·Filed 2016·Granted Oct 15, 2019·0 cites·12 claims
- 3156US2016271219A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2016·Application pending·0 cites
- 3255US11166995B2Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitorUNIV OSAKA·Filed 2017·Granted Nov 9, 2021·0 cites·6 claims
- 3354US2008207552A1Decoy compositions for treating and preventing brain diseases and disordersANGES MG INC·Filed 2007·Application pending·0 cites
- 3453US2009202500A1Pharmaceuticals That Promote Functional Regeneration of Damaged TissuesGENOMIX CO LTD·Filed 2007·Application pending·0 cites
- 3551US2023233705A1Gold nanoparticle-containing medicineUNIV OSAKA·Filed 2021·Application pending·0 cites
- 3649US2011097309A1Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged TissueTAMAI KATSUTO·Filed 2009·Application pending·0 cites
- 3748US2006099597A1Method of isolating nucleic acid having desired functional property and kit thereforKANEDA YASUFUMI·Filed 2003·Application pending·0 cites
- 3847US9012417B2Topical administration of NF-kappaB decoy to treat atopic dermatitisMORISHITA RYUICHI·Filed 2002·Granted Apr 21, 2015·0 cites·4 claims
- 3947US2004253272A1Process for producing inactivated virus envelopesFiled 2002·Application pending·0 cites
- 4044US2006135449A1Decoy compositions for treating and preventing brain diseases and disordersSAWA YOSHIKI·Filed 2002·Application pending·0 cites
- 4143US2022202846A1Immunostimulating compositionUNIV OSAKA·Filed 2020·Application pending·0 cites
- 4243US2011268769A1Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the sameKANEDA YASUFUMI·Filed 2011·Application pending·0 cites
- 4343US2007287677A1Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses ThereofGENOMLDEA INC·Filed 2005·Application pending·0 cites
- 4442US2019358276A1Novel therapeutic agent for prionoid diseasesUNIV OSAKA·Filed 2017·Application pending·0 cites
- 4540US2009082263A1Drug and method for improving brain functionANGES MG INC·Filed 2005·Application pending·0 cites
- 4637US9458429B2Mesenchymal stem cell attractant and method for attracting mesenchymal stem cellKITAMURA KEIKO·Filed 2011·Granted Oct 4, 2016·0 cites·9 claims
- 4735US9486465B2Attractant for bone marrow stem cells and method for attracting bone marrow stem cellsPIAS CORP·Filed 2013·Granted Nov 8, 2016·0 cites·5 claims
- 4831US2016367616A1Mesenchymal stem cell attractant and method for attracting mesenchymal stem cellPIAS CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasufumi Kaneda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →